Aktieanalys

Lipigon: Phase II Study Fully Recruited - Redeye

{newsItem.title}

Redeye Publicerad: 24 Jun 07:22

Lipigon Pharmaceuticals

Redeye thinks the phase II study is now on track, with the last patient recruited and preliminary results expected in six months from now.

Länk till analysen i sin helhet: https://www.redeye.se/research/1116086/lipigon-phase-ii-study-fully-recruited?utm_source=finwire&utm_medium=RSS

Nyheter om Lipigon Pharmaceuticals

Läses av andra just nu

Om aktien Lipigon Pharmaceuticals

Senaste nytt